Literature DB >> 3947524

Is driving gas flow rate clinically important for nebulizer therapy?

J W Hadfield, W J Windebank, J R Bateman.   

Abstract

Ten patients with stable asthma were studied to see whether the flow rate used to drive a nebulizer was clinically important. Each received 1 mg of salbutamol in 2 ml of physiological saline via a Sandoz 'Lifeline' nebulizer driven by piped oxygen at 8, 6 and 4 litres/min on separate randomly allocated occasions. Although the time for nebulization was significantly longer as flow rate was reduced, there was no significant difference in the bronchodilator response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947524     DOI: 10.1016/0007-0971(86)90009-4

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  5 in total

Review 1.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors:  Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

Review 2.  The science of nebulised drug delivery.

Authors:  C O'Callaghan; P W Barry
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Inaccurate calculation of drug output from nebulisers.

Authors:  C O'Callaghan; A R Clarke; A D Milner
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

4.  Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

Authors:  M M Clay; S W Clarke
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

5.  Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.

Authors:  D M Mitchell; M A Solomon; S E Tolfree; M Short; S G Spiro
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.